These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18768938)

  • 1. Identifying and addressing safety signals in clinical trials.
    Fleming TR
    N Engl J Med; 2008 Sep; 359(13):1400-2. PubMed ID: 18768938
    [No Abstract]   [Full Text] [Related]  

  • 2. Ezetimibe and cancer--an uncertain association.
    Drazen JM; D'Agostino RB; Ware JH; Morrissey S; Curfman GD
    N Engl J Med; 2008 Sep; 359(13):1398-9. PubMed ID: 18765434
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
    N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of cancer data from three ezetimibe trials.
    Peto R; Emberson J; Landray M; Baigent C; Collins R; Clare R; Califf R
    N Engl J Med; 2008 Sep; 359(13):1357-66. PubMed ID: 18765432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
    Green A; Ramey DR; Emneus M; Iachina M; Stavem K; Bolin K; McNally R; Busch-Sørensen M; Willenheimer R; Egstrup K; Kesäniemi YA; Ray S; Basta N; Kent C; Pedersen TR
    Am J Cardiol; 2014 Nov; 114(10):1518-22. PubMed ID: 25267716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary observations from preliminary trial results: have we finally had enough?
    Taylor AJ; Nissen SE
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):54-7. PubMed ID: 20031788
    [No Abstract]   [Full Text] [Related]  

  • 7. Premature release of data from clinical trials of ezetimibe.
    Califf RM; Harrington RA; Blazing MA
    N Engl J Med; 2009 Aug; 361(7):712-7. PubMed ID: 19675335
    [No Abstract]   [Full Text] [Related]  

  • 8. Don't mess with the DSMB.
    Drazen JM; Wood AJ
    N Engl J Med; 2010 Jul; 363(5):477-8. PubMed ID: 20647188
    [No Abstract]   [Full Text] [Related]  

  • 9. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589
    [No Abstract]   [Full Text] [Related]  

  • 10. At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.
    Hamilton-Craig I; Kostner K; Colquhoun D; Woodhouse S
    Heart Lung Circ; 2009 Oct; 18(5):343-6. PubMed ID: 19586799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
    Mitka M
    JAMA; 2009 Feb; 301(8):813-5. PubMed ID: 19244181
    [No Abstract]   [Full Text] [Related]  

  • 13. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of familial hypercholesterolemia with or without ezetimibe].
    Berthold HK; Nitschmann S
    Internist (Berl); 2008 Oct; 49(10):1274-6. PubMed ID: 18754087
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of simultaneous acute pancreatitis and acute hepatitis in a patient taking ezetimibe/simvastatin.
    Van Woerkom RC; Adler DG
    J Clin Lipidol; 2010; 4(4):314-5. PubMed ID: 21122666
    [No Abstract]   [Full Text] [Related]  

  • 18. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
    Holme I; Boman K; Brudi P; Egstrup K; Gohlke-Baerwolf C; Kesäniemi YA; Malbecq W; Rossebø AB; Wachtell K; Willenheimer R; Pedersen TR
    Am J Cardiol; 2010 Jun; 105(12):1802-8. PubMed ID: 20538134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe revisited.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.